Prevalence of Diabetic Peripheral Neuropathy Among Type 2 Diabetes mellitus and Its Associated Factors in a Primary Care Clinic in Malacca: A Cross-sectional Study

Article Sidebar

Published: Sep 30, 2024
DOI: https://doi.org/10.47836/mjmhs20.5.28
Keywords:
Diabetes, Peripheral neuropathy, Prevalence, Primary care, Malaysia, Factor

Main Article Content

Hanifatiyah Ali
Department of Family Medicine, Faculty Medicine and Science Health, University Putra Malaysia 43400 Serdang, Selangor, Malaysia.
Janarisa Mustar May
Klinik Kesihatan Long Lama, Jalan Long Lama – Miri, 98300 Long Lama Telang Usan, Sarawak, Malaysia.
Lee Ping Yein3
UMeHealth Unit, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur, Malaysia
Aneesa Abdul Rashid
Department of Family Medicine, Faculty Medicine and Science Health, University Putra Malaysia 43400 Serdang, Selangor, Malaysia.

Abstract

Introduction: Diabetes peripheral neuropathy (DPN) is the commonest diabetic complication. This study aimed to determine the prevalence of diabetic peripheral neuropathy among type 2 diabetes mellitus patients and its associated factors in a primary care clinic. Materials and methods: A cross sectional study was done in a government funded primary care clinic in Melaka involving type 2 diabetes mellitus patients aged 18 years and above using a systematic random sampling. Multiple logistic regression analysis was performed to identify its associated factors. Results: 493 respondents were involved in the study with a median age of 62 (IQR 14) and 43.4% per cent (n=214) male. The prevalence of DPN in this study was 58.4% per cent (n=288). Age (OR:1.05; 95% per cent CI: 1.04 – 1.07), insulin treatment (OR: 3.28; 95% per cent CI: 1.99 – 5.40), and presence of albuminuria (OR:1.74; 95% per cent CI: 1.17 – 2.60) were found to be significantly associated with DPN. Conclusion: The prevalence of DPN is high in primary care setting in Malaysia. To enhance detection of DPN, multimodal foot examination should be performed especially among patients aged >60 years old, those on insulin treatment and those with presence of albuminuria.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ali, H., May, J. M., Yein3, L. P., & Abdul Rashid, A. (2024). Prevalence of Diabetic Peripheral Neuropathy Among Type 2 Diabetes mellitus and Its Associated Factors in a Primary Care Clinic in Malacca: A Cross-sectional Study. Malaysian Journal of Medicine and Health Sciences, 20(5), 219–225. https://doi.org/10.47836/mjmhs20.5.28
Issue
Vol. 20 No. 5 (2024)
Section
Original Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Prim. 2019 Jun;5(1):41. doi: 10.1038/s41572-019-0092-1

Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993 Feb;36(2):150–4. doi: 10.1007/BF00400697

Won JC, Kim SS, Ko KS, Cha B-Y. Current status of diabetic peripheral neuropathy in Korea: report of a hospital-based study of type 2 diabetic patients in Korea by the diabetic neuropathy study group of the korean diabetes association. Diabetes Metab J. 2014 Feb;38(1):25–31. doi: 10.4093/dmj.2014.38.1.25

Ab F, Na A, Sn A, Faa A, Mza H, M N. Risk Determinants of Peripheral Neuropathy in Patients with Type II Diabetes Mellitus Attending Follow-Up Clinics at Universiti Kebangsaan Malaysia Medical Center ( UKMMC ): A Cross-Sectional Study. Med Heal. 2010;5(1):34–40.

Goh LY, Shahrom EE, Ganesan CC, Vethakkan SR, Goh KJ. The prevalence and associated factors of neuropathic pain symptoms in a cohort of multi-ethnic Malaysian patients with diabetes mellitus. Neurol Asia. 2017;22(4):325–31.

Abougalambou SSI, Abougalambou AS. Explorative study on diabetes neuropathy among type II diabetic patients in Universiti Sains Malaysia Hospital. Diabetes Metab Syndr. 2012;6(3):167–72. doi: 10.1016/j.dsx.2012.09.002

Mafauzy M, Hussein Z, Chan SP. The status of diabetes control in Malaysia: results of DiabCare 2008. Med J Malaysia. 2011 Aug;66(3):175–81.

Chawla A, Bhasin GK, Chawla R. Validation Of Neuropathy Symptoms Score (NSS) And Neuropathy Disability Score (NDS ) In The Clinical Diagnosis Of Peripheral Neuropathy In Middle Aged People With Diabetes. Internet J Fam Pract [Internet]. 2013;12. Available from: https://api.semanticscholar.org/CorpusID:57417154

Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia. 2003 Oct;58(4):533–8.

Cohen JA, Gross KF. Peripheral neuropathy: causes and management in the elderly. Geriatrics. 1990 Feb;45(2):21-26,31-34.

Zakariah N, Chandran A. National Diabetes Registry Report 2020. 2021. doi: 10.13140/RG.2.2.12409.60004

Lee YK, Ng CJ, Lee PY, Khoo EM, Abdullah KL, Low WY, et al. What are the barriers faced by patients using insulin? A qualitative study of Malaysian health care professionals’ views. Patient Prefer Adherence. 2013;7:103–9. doi: 10.2147/PPA.S36791

Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Ann Saudi Med. 2007;27(1):25–31. doi: 10.5144/0256-4947.2007.25

Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 2007 Nov;9(6):781–91. doi: 10.1111/j.1463-1326.2007.00670.x

Sui T, Johari M, Perialathan K, Ahmad M, Juatan N,Jaafar F. NHMS 2019 Technical Report - Volume 1 NCD Risk Factors and other health problem (Health Literacy Page 260-262, 284). 2020.